Skip to content
Company Details
Team
Resources
RayzeBio
Defeating cancer with radiopharmaceutical medicines
Industry
Biotechnology Research
Headquarters
San Diego, CA
Company Size
75+ employees
Leader in targeted radiopharmaceuticals to improving cancer patient survival. Broad pipeline of innovative drugs against solid tumor targets.
News
RayzeBio Completes Phase 1b Enrollment in ACTION-1 Study, Evaluating RYZ101 (Actinium-225 DOTATATE) in Neuroendocrine Tumors
RayzeBio Announces Issuance of Two Patents for RYZ101 (225Ac-DOTATATE)
Building career-spanning relationships, from candidacy to organizational leadership, we provide access to the future of the Medtech and Pharma.
Work For Us
Contact Us